Simon Glairy is a formidable presence in the world of financial risk management, recognized for his deep understanding of how insurers navigate the volatile intersection of regulatory compliance and operational resilience. As an expert in Insurtech and AI-driven risk assessment, Glairy has spent years helping firms translate complex legislative mandates into actionable business strategies. In this discussion, we dive into the impending shift in UK regulation—the Prudential Regulation Authority’s new solvent exit planning regime. This framework is not merely a new set of rules but a fundamental change in how the industry views its own mortality. We explore why the transition to the June 30, 2026, deadline is proving to be such a monumental task for the 370 firms in scope, the hidden dangers of using standardized templates, and how these plans serve as a litmus test for an insurer’s true character and governance.
The Financial Services Compensation Scheme has paid out £1.3 billion over a ten-year period due to insurance failures. In your view, how does this staggering figure explain the PRA’s urgency in enforcing the new solvent exit planning regime?
That £1.3 billion figure is more than just a data point; it represents a significant burden on the industry and a traumatic experience for thousands of policyholders who were left in limbo. When you look at the decade between 2013 and 2023, that level of compensation indicates that the current mechanisms for managing insurer exits were often reactive rather than proactive. The PRA is sending a clear message that the days of “muddling through” a failure are over. By requiring firms to have a Solvent Exit Analysis ready by the end of June, the regulator is essentially demanding that every company has a pre-written manual for its own graceful departure. It’s about shifting the financial and operational risk away from the public safety net and back onto the firms themselves, ensuring that if a company must cease operations, it does so without triggering a systemic shock or a massive bill for the FSCS.
Many industry experts suggest that firms have underestimated the sheer scale of creating a Solvent Exit Analysis. Why is it so difficult to determine the “minimum financial resources” needed for an exit compared to standard capital requirements?
The mistake many boards make is assuming that their Solvency Capital Requirement or Minimum Capital Requirement already covers this scenario, but the reality is far more complex. A solvent exit is not a theoretical stress test; it is a practical, step-by-step execution plan that accounts for the unique friction of winding down a specific business model. You have to account for the costs of maintaining staff during a run-off, the legal fees for transferring portfolios, and the potential dip in asset values during a forced sale. Because every insurer has a different mix of products and corporate structures—especially the complex mutuals—there is no one-size-fits-all number. Identifying that specific financial floor requires a level of granular honesty about operational costs that many firms simply haven’t had to document in this way before.
With roughly 370 firms affected, and 97% of them being small to medium-sized insurers, there is a significant “compliance crunch.” What are the primary risks for these smaller players who might be tempted to rely on standardized templates to meet the deadline?
There is a very real danger that smaller firms will view this as a “box-ticking” exercise and reach for a generic template just to satisfy the supervisors on July 1. However, the PRA has been very deliberate in not providing a standard form because they want to see the “fingerprints” of the firm’s specific risks on the document. A template might help you meet a deadline, but it won’t help you identify the specific operational barriers, like a complex corporate structure or a niche product line, that could turn a solvent exit into a chaotic collapse. Smaller insurers often lack the deep reserves of historical data that larger firms have, meaning they have to build these plans from scratch with very little prior experience. If they don’t treat this as a bespoke strategic exercise, they risk producing a plan that looks good on paper but fails the moment a supervisor asks a difficult question about their specific business model.
The new framework emphasizes the identification of operational barriers. Based on the market’s current progress, what are some of the most common “tripwires” that firms are surfacing during this process?
One of the most significant tripwires is the sheer difficulty of gathering cohesive information from across different silos of the business. You might have the actuarial team understanding the capital side, but the legal and operational teams might not have a clear picture of what happens to policyholder services during a phased exit. We are seeing firms struggle with the complexities of mutual structures, where the path to an orderly exit is hampered by constitutional requirements that don’t exist for standard corporations. Additionally, many firms are finding that their existing information, while sufficient for day-to-day operations, isn’t detailed enough to support the “decision-making triggers” the PRA expects to see. It’s a sensory overload for many companies as they realize how interconnected their exit strategy is with their range of products and their systemic importance.
The PRA now has the power to vary or cancel a firm’s Part 4A permissions if they fail to engage with this planning. How do you see this impacting the relationship between insurers and their supervisors moving forward?
The stakes have shifted from a collaborative “wait and see” approach to a regime where the intensity of supervision is directly linked to the quality of your exit plan. If a firm shows persistent or material failure to engage with the SEA process, the PRA won’t hesitate to use its powers under the Financial Services and Markets Act 2000. This creates a high-pressure environment where the supervisor is no longer just looking at your current balance sheet, but also at your “funeral arrangements.” It forces a more transparent dialogue, but it also means that firms with weak governance will find themselves under a microscope much earlier than they might have anticipated. In essence, your exit plan has become a proxy for your overall management quality, and a poor plan could lead to restricted permissions before you even face a real financial crisis.
How can a well-constructed Solvent Exit Analysis actually improve a company’s day-to-day business strategy and operational resilience, rather than just being a “death plan”?
When a board sits down to truly map out an exit, they are forced to confront the hidden costs and complexities of every single product they sell. This process often shines a light on business lines that are disproportionately expensive to run or exit, which can lead to a much more disciplined approach to risk appetite and overall strategy. It encourages a level of operational resilience because you’re essentially stress-testing your infrastructure against the most extreme scenario possible—the end of the business. By understanding the “point of no return,” boards can make better decisions about capital allocation and long-term partnerships. It’s about building a stronger, more transparent company by acknowledging that the ability to leave the market gracefully is just as important as the ability to compete in it.
Brokers and policyholders might feel this is an internal regulatory matter, but why is it vital for them to know that an insurer has a robust exit strategy in place?
For a broker, the primary mission is to place a client with an insurer that will be there to pay claims five, ten, or even twenty years down the line. An insurer that has thought carefully about how it would exit the market is demonstrating the kind of governance and risk management that makes them a reliable partner in the present. If an insurer hasn’t planned for an orderly run-off, the policyholder is the one who suffers through delayed claims and uncertainty if things go south. A firm with a solid SEA is essentially proving they have the character to protect their clients even in the worst-case scenario. It gives the broker peace of mind that their recommendation is backed by a company that prioritizes policyholder protection over a messy, unmanaged exit.
What is your forecast for the UK insurance landscape once these solvent exit plans become a permanent fixture of the regulatory environment?
I expect we will see a significant consolidation in the market as smaller firms realize the sheer cost and complexity of maintaining the governance standards the PRA now requires. The “zombie” insurers—those that are barely surviving but haven’t yet failed—will be forced to confront their reality much sooner, leading to a healthier, more robust industry overall. We will also see a rise in more sophisticated risk management tools, likely driven by AI, as firms seek to automate the monitoring of the firm-specific indicators that trigger an exit. Ultimately, the industry will become more transparent and resilient, but the path to get there will be paved with difficult decisions for boards who have historically avoided thinking about the end of the road. It’s a “survival of the most prepared” era, and those who embrace the SEA as a governance tool will be the ones who thrive.
